Steffen Pfeuffer (S Pfeuffer)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 22

Top Topics

Community Dwelling

Stem Cell Transplantation

Atopic Dermatitis

Multiple Sclerosis

Top Venues

Multiple sclerosis (Houndmills, Basingstoke, England)

Neurology(R) neuroimmunology & neuroinflammation

European journal of neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Steffen Pfeuffer, Stephanie Wolff, Derya Aslan, Leoni Rolfes, Melanie Korsen, Marc Pawlitzki, Philipp Albrecht, Joachim Havla, Hagen B Huttner, Christoph Kleinschnitz, Sven Guenther Meuth, Refik Pul, Tobias Ruck
Association of Clinical Relapses With Disease Outcomes in Multiple Sclerosis Patients Older Than 50 Years. Neurology 103 (2) (2024)
Steffen Pfeuffer
Psoriasisform dermatitis following anti-CD20 therapies: Immunologic lessons and management dilemmas. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (7) (2024)
Steffen Pfeuffer
Psoriasisform dermatitis following anti-CD20 therapies: Immunologic lessons and management dilemmas. Multiple sclerosis (Houndmills, Basingstoke, England) (2024)
Steffen Pfeuffer
Psoriasisform dermatitis following anti-CD20 therapies: Immunologic lessons and management dilemmas. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (7) (2024)
Steffen Pfeuffer
Psoriasisform dermatitis following anti-CD20 therapies: Immunologic lessons and management dilemmas. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (7) (2024)
Steffen Pfeuffer
Psoriasisform dermatitis following anti-CD20 therapies: Immunologic lessons and management dilemmas. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (7) (2024)
Steffen Pfeuffer, Stephanie Wolff, Derya Aslan, Leoni Rolfes, Melanie Korsen, Marc Pawlitzki, Philipp Albrecht, Joachim Havla, Hagen B Huttner, Christoph Kleinschnitz, Sven Guenther Meuth, Refik Pul, Tobias Ruck
Association of Clinical Relapses With Disease Outcomes in Multiple Sclerosis Patients Older Than 50 Years. Neurology 103 (2) (2024)
Steffen Pfeuffer, Leoni Rolfes, Jens Ingwersen, Refik Pul, Konstanze Kleinschnitz, Melanie Korsen, Saskia J Raeuber, Tobias Ruck, Simon Schieferdecker, Alice Grizzel Willison, Orhan Aktas, Christoph Kleinschnitz, Hans-Peter Hartung, Ludwig Kappos, Sven G Meuth
Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With Ocrelizumab. Neurology(R) neuroimmunology & neuroinflammation 10 (3) (2023)
Tobias Ruck, Sumanta Barman, Andreas Schulte-Mecklenbeck, Steffen Pfeuffer, Falk Steffen, Christopher Nelke, Christina B Schroeter, Alice Willison, Michael Heming, Thomas Müntefering, Nico Melzer, Julia Krämer, Maren Lindner, Marianne Riepenhausen, Catharina C Gross, Luisa Klotz, Stefan Bittner, Paolo A Muraro, Tilman Schneider-Hohendorf, Nicholas Schwab, Gerd Meyer Zu Hörste, Norbert Goebels, Sven G Meuth, Heinz Wiendl
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity. Brain : a journal of neurology 145 (5) (2022)
Steffen Pfeuffer, Leoni Rolfes, Jana Hackert, Konstanze Kleinschnitz, Tobias Ruck, Heinz Wiendl, Luisa Klotz, Christoph Kleinschnitz, Sven G Meuth, Refik Pul
Effectiveness and safety of cladribine in MS: Real-world experience from two tertiary centres. Multiple sclerosis (Houndmills, Basingstoke, England) (2021)
Steffen Pfeuffer, Laura Kerschke, Tobias Ruck, Leoni Rolfes, Marc Pawlitzki, Philipp Albrecht, Heinz Wiendl, Sven G Meuth
Teriflunomide treatment is associated with optic nerve recovery in early multiple sclerosis. Therapeutic advances in neurological disorders 14 (2021)
Leoni Rolfes, Steffen Pfeuffer, Jana Hackert, Marc Pawlitzki, Tobias Ruck, Wiebke Sondermann, Melanie Korsen, Heinz Wiendl, Sven G Meuth, Christoph Kleinschnitz, Refik Pul
Skin Reactions in Patients With Multiple Sclerosis Receiving Cladribine Treatment. Neurology(R) neuroimmunology & neuroinflammation 8 (3) (2021)
Steffen Pfeuffer, Tobias Ruck, Refik Pul, Leoni Rolfes, Catharina Korsukewitz, Marc Pawlitzki, Brigitte Wildemann, Luisa Klotz, Christoph Kleinschnitz, Antonio Scalfari, Heinz Wiendl, Sven G Meuth
Impact of previous disease-modifying treatment on effectiveness and safety outcomes, among patients with multiple sclerosis treated with alemtuzumab. Journal of neurology, neurosurgery, and psychiatry 92 (9) (2021)
Kristina Schönfelder, Helene Schuh, Frederick Pfister, Julia Krämer, Ute Eisenberger, Jelena Skuljec, Jana Hackert, Tobias Ruck, Steffen Pfeuffer, Michael Fleischer, Anja Gäckler, Tim Hagenacker, Andreas Kribben, Sven G Meuth, Christoph Kleinschnitz, Refik Pul
Autoimmune glomerulonephritis in a multiple sclerosis patient after cladribine treatment. Multiple sclerosis (Houndmills, Basingstoke, England) 27 (12) (2021)
Leoni Rolfes, Andreas Schulte-Mecklenbeck, Stefanie Schreiber, Stefan Vielhaber, Michael Herty, Anika Marten, Steffen Pfeuffer, Tobias Ruck, Heinz Wiendl, Catharina C Gross, Sven G Meuth, Matthias Boentert, Marc Pawlitzki
Amyotrophic lateral sclerosis patients show increased peripheral and intrathecal T-cell activation. Brain communications 3 (3) (2021)
Melanie Eschborn, Marc Pawlitzki, Timo Wirth, Christopher Nelke, Steffen Pfeuffer, Andreas Schulte-Mecklenbeck, Lisa Lohmann, Leoni Rolfes, Katrin Pape, Maria Eveslage, Stefan Bittner, Catharina C Gross, Tobias Ruck, Heinz Wiendl, Sven G Meuth, Luisa Klotz
Evaluation of Age-Dependent Immune Signatures in Patients With Multiple Sclerosis. Neurology(R) neuroimmunology & neuroinflammation 8 (6) (2021)
Leoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer, Christopher Nelke, Anke Lux, Refik Pul, Christoph Kleinschnitz, Konstanze Kleinschnitz, Rebeca Rogall, Katrin Pape, Stefan Bittner, Frauke Zipp, Clemens Warnke, Yasemin Goereci, Michael Schroeter, Jens Ingwersen, Orhan Aktas, Luisa Klotz, Tobias Ruck, Heinz Wiendl, Sven G Meuth
Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19. Neurology(R) neuroimmunology & neuroinflammation 8 (5) (2021)
Steffen Pfeuffer, Sven Guenther Meuth
Stem cell transplantation and alemtuzumab - options for 'early reprogramming' in multiple sclerosis? European journal of neurology 27 (10) (2020)
Steffen Pfeuffer, Tobias Ruck, Leoni Rolfes, Matthias Pawlowski, Marc Pawlitzki, Heinz Wiendl, Stjepana Kovac, Sven Guenther Meuth
Patients with a relapsing course of steroid-responsive encephalopathy associated with autoimmune thyroiditis exhibit persistent intrathecal CD4+ T-cell activation. European journal of neurology 28 (4) (2020)
Steffen Pfeuffer, Matthias Pawlowski, Gunther S Joos, Jens Minnerup, Sven G Meuth, Rainer Dziewas, Heinz Wiendl
Autoimmunity complicating SARS-CoV-2 infection in selective IgA-deficiency. Neurology(R) neuroimmunology & neuroinflammation 7 (6) (2020)
Steffen Pfeuffer
Sarcoidosis following alemtuzumab treatment: Autoimmunity mediated by T cells and interferon-γ. Multiple sclerosis (Houndmills, Basingstoke, England) 24 (13) (2018)
Steffen Pfeuffer, Rene Schmidt, Frederike Anne Straeten, Refik Pul, Christoph Kleinschnitz, Marinus Wieshuber, De-Hyung Lee, Ralf A Linker, Sebastian Doerck, Vera Straeten, Susanne Windhagen, Marc Pawlitzki, Christoph Aufenberg, Michael Lang, Christian Eienbroeker, Björn Tackenberg, Volker Limmroth, Brigitte Wildemann, Jürgen Haas, Luisa Klotz, Heinz Wiendl, Tobias Ruck, Sven G Meuth
Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation. Journal of neurology 266 (1) (2018)